Author(s):
Kadeeja Vadakkan. Rajesh KS, Smitha Tarachandra, Bharath Raj KC, Himanshu Joshi
Email(s):
vadakkan.kadeeja@gmail.com , kaverikaa@gmail.com , drsmitha9@gmail.com
DOI:
10.52711/0974-360X.2022.00896 
Address:
Kadeeja Vadakkan1. Rajesh KS2, Smitha Tarachandra3, Bharath Raj KC1, Himanshu Joshi4
1Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, Department of Pharmacy Practice, Derlakatte, Mangaluru, Karnataka, India-575018.
2Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, Department of Pharmacology, Derlakatte, Mangaluru, Karnataka, India 575018.
3Nitte (Deemed to be University), K S Hegde Medical Academy, Department of Psychiatry, Derlakatte, Mangaluru, Karnataka, India-575018.
4College of Pharmacy, Graphic Era Hill University, Bhimtal Campus, Uttarakhand, India 263136.
*Corresponding Author
Published In:
Volume - 15,
Issue - 11,
Year - 2022
ABSTRACT:
Background: Alcohol dependence is one of the common psychiatric disorder which is characterized by a pathological pattern of alcohol use, effecting mental health. Patients show severe symptoms, requiring clinical intervention. Benzodiazepines treatment can decrease the severity of withdrawal symptoms, and incidence of seizures and delirium tremens after abrupt cessation of alcohol. Objectives: To check the severity of alcohol use and assess the alcohol withdrawal symptoms, and to monitor the efficacy of different Benzodiazepines in alcohol detoxification. Methodology: A prospective study of eight months’ duration, conducted in the de-addiction unit attached to Psychiatric department (in-patients). A suitable data collection form was designed. All patients were screened using AUDIT scale and CIWA-Ar scale was used to assess the duration and severity of AWS. Data were analysed using descriptive statistics. Results: 220 patients were included in the study. Mean AUDIT score was 25.74, all the patients scored 8 or more on AUDIT. Majority of the patients were observed to have an AUDIT score between 25-32. A gradual decrease of signs and symptoms in each patient were observed. All patients were prescribed with Benzodiazepine, among which 135 (61.36%) patients were prescribed with Lorazepam followed by 85 (38.63%) patients with Diazepam and Chlordiazepoxide. Conclusion: Even though both Lorazepam and Diazepam are equally effective Benzodiazepines, in the present study, we observed that Lorazepam is the most commonly prescribed. The choices of drugs differ for each patient, and is patient specific. The management works best when it is individualized with the help of rating scales.
Cite this article:
Kadeeja Vadakkan. Rajesh KS, Smitha Tarachandra, Bharath Raj KC, Himanshu Joshi. Clinical utility of benzodiazepine in the management of alcohol withdrawal syndrome in a tertiary care teaching hospital. Research Journal of Pharmacy and Technology. 2022; 15(11):5321-6. doi: 10.52711/0974-360X.2022.00896
Cite(Electronic):
Kadeeja Vadakkan. Rajesh KS, Smitha Tarachandra, Bharath Raj KC, Himanshu Joshi. Clinical utility of benzodiazepine in the management of alcohol withdrawal syndrome in a tertiary care teaching hospital. Research Journal of Pharmacy and Technology. 2022; 15(11):5321-6. doi: 10.52711/0974-360X.2022.00896 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-11-81
REFERENCES:
1. Shivani R, Goldsmith RJ, Anthenelli RM. Alcoholism and Psychiatric Disorders: Diagnostic Challenges. Alcohol Research and Health. 2002;26(2):90–8.
2. Jesse S, Bråthen G, Ferrara M, Keindl M, Ben-Menachem E, Tanasescu R, et al. Alcohol withdrawal syndrome: mechanisms, manifestations, and management. Acta Neurologica Scandinavica. 2017;135(1):4–16. doi: 10.1111/ane.12671
3. Kattimani S, Bharadwaj B. Clinical management of alcohol withdrawal: A systematic review. Industrial Psychiatry Journal. 2013;22(2):100–8. doi: 10.4103/0972-6748.132914.
4. Sachdeva A, Choudhary M, Chandra M. Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond. Journal of Clinical and Diagnostic Research2015;9(9):VE01–7. doi: 10.7860/JCDR/2015/13407.6538
5. Alcohol withdrawal. 2018 [cited 2021 Jun 1]. Available from: https://www.elsevier.com/__data/assets/pdf_file/0016/1010275/Alcohol-withdrawal_CO_140918.pdf
6. Kaskutas LA. Alcoholics anonymous effectiveness: faith meets science. Journal of Addictive Diseases. 2009;28(2):145-157. doi:10.1080/10550880902772464
7. Akbar M, Egli M, Cho Y-E, Song B-J, Noronha A. Medications for alcohol use disorders: An overview. Pharmacology & Therapeutics. 2018;185:64–85. doi: 10.1016/j.pharmthera.2017.11.007.
8. Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146(6):1513–24. doi: 10.1053/j.gastro.2014.01.020.
9. Alcohol Facts and Statistics. National Institute on Alcohol Abuse and Alcoholism. [cited 2021 Jun 1]. Available from: https://bit.ly/353Oyix
10. Parag S. Mahadik, Senthilkumar G.P., Amol S. Powar, Devprakash D., Tamizh Mani T. SAG. Chemical and Biological Properties of Benzodiazepines- An overview. Research Journal of Pharmacy and Technology (RJPT). 2012;5(2):181–9.
11. Maldonado JR, Sher Y, Das S, Hills-Evans K, Frenklach A, Lolak S, et al. Prospective Validation Study of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in Medically Ill Inpatients: A New Scale for the Prediction of Complicated Alcohol Withdrawal Syndrome. Alcohol Alcohol. 2015; 50(5): 509–18. https://doi.org/10.1093/alcalc/agv043
12. Indra V, Mony. Effect of Specific Nursing Intervention Programme on Relapse Prevention of Clients with Alcohol Dependence Syndrome. Nurse Care Open Access Journal. 2018;6(3):256. DOI: 10.15406/ncoaj.2017.04.00099
13. Vimala G. Marital Satisfaction and Burden among Wives of men with Alcohol Dependence Attending at Psychiatric OPD of Pravara Rural Hospital. Int J Adv Nurs Manag. 2016;4(4):361. DOI: 10.5958/2454-2652.2016.00080.9
14. Harmful use of alcohol kills more than 3 million people each year, most of them men. 2018 [cited 2021 Jun 10]. Available from: https://www.who.int/news/item/21-09-2018-harmful-use-of-alcohol-kills-more-than-3-million-people-each-year--most-of-them-men
15. Paul C, Rose S, Shamina VK, Asokan S, Litty S, Paul S, et al. Assessment of Level of Codependency and Quality of Marital Life among Spouses of Patients with Alcohol Dependence Syndrome. International Journal of Nursing Education and Research. 2018;6(4):374. DOI : 10.5958/2454-2660.2018.00091.1
16. Elliott DY. Caring for hospitalized patients with alcohol withdrawal syndrome. Nursing Critical Care. 2019;14(5). doi: 10.1097/01.CCN.0000578828.37034.c2
17. Halim S, Mohamad N, Toriman ME, Bakar NHA, Hashim SN, Adnan LHM, et al. Role of Zamzam water as a vital mineral supplement in the treatment of opioid dependence and tolerance: a review. Research Journal of Pharmacy and Technology. 2016;9(7):957–63. DOI: 10.5958/0974-360X.2016.00183.9
18. Adinoff B. Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings. Alcoholism: Clinical and Experimental Research. 1994 Aug;18(4):873–8. doi: 10.1111/j.1530-0277.1994.tb00053.x.
19. Sellers EM, Naranjo CA, Harrison M, Devenyi P, Roach C, Sykora K. Diazepam loading: simplified treatment of alcohol withdrawal. Clinical Pharmacology and Therapeutics. 1983 Dec;34(6):822–6. doi: 10.1038/clpt.1983.256.
20. Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised (CIWA-Ar). [cited 2021 Jan 2]. Available from: https://umem.org/files/uploads/1104212257_CIWA-Ar.pdf
21. Mirijello A, D’Angelo C, Ferrulli A, Vassallo G, Antonelli M, Caputo F, et al. Identification and management of alcohol withdrawal syndrome. Drugs. 2015;75(4):353–65. doi: 10.1007/s40265-015-0358-1.
22. James D, Nazar N. Role of anti-anxiety drugs in patient cooperation during minor surgical procedure. Research Journal of Pharmacy and Technology. 2018;11(8):3389–91. DOI: 10.5958/0974-360X.2018.00624.8
23. Becker HC. Alcohol dependence, withdrawal, and relapse. Alcohol Ressearch and Health. 2008;31(4):348–61.
24. Khose RD, Jaydeokar A V., Patil US, Bagul PP, Bandawane DD, Chaudhari PD. Receptor pharmacology of GABA: A review. Research Journal of Pharmacy and Technology. 2012;5(6):721–8. DOI: 10.5958/0974-360X.2020.00886.0
25. Elholm B, Larsen K, Hornnes N, Zierau F, Becker U. Alcohol withdrawal syndrome: symptom-triggered versus fixed-schedule treatment in an outpatient setting. Alcohol Alcohol. 2011;46(3):318–23. doi: 10.1093/alcalc/agr020
26. Sharp B, Schermer CR, Esposito TJ, Omi EC, Ton-that H, Santaniello JM. Alcohol Withdrawal Syndrome in Trauma Patients : A Prospective Cohort Study. Journal of Trauma & Treatment. 2012;1(4):1–4.
27. Dolman JM, Hawkes ND. Combining the audit questionnaire and biochemical markers to assess alcohol use and risk of alcohol withdrawal in medical inpatients. Alcohol Alcohol. 2005;40(6):515–9. DOI: 10.4172/2167-1222.1000128
28. Nagarathna PKM, Harsha Vardhini N, Babiker B, Mahesh Kumar CS, Chandanam S. Development of subtype selective gabaa modulators: A review article. . Research Journal of Pharmacy and Technology. 2019;12(8):3967–72. DOI: 10.5958/0974-360X.2019.00683.8
29. Weaver MF, Hoffman HJ, Johnson RE, Mauck K. Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidity. Journal of Addictive Diseases. 2006;25(2):17–24. doi: 10.1300/j069v25n02_03.
30. Fiellin DA, Reid MC, O’Connor PG. Screening for Alcohol Problems in Primary Care: A Systematic Review. archives of internal medicine. 2000;160(13):1977–89. https://doi.org/10.1001/archinte.160.13.1977
31. Vishwas A. An Observational Study to Assess the Nicotine Dependence among Tobacco users in selected rural Areas of Udaipur (Raj). International journal of advances in nursing management. 2019;7(3):194. DOI : 10.5958/2454-2652.2019.00045.3
32. Ntais C, Pakos E, Kyzas P, Ioannidis JPA. Benzodiazepines for alcohol withdrawal. Cochrane Database of Systematic Reviews . 2005 Jul;(3):CD005063. doi: 10.1002/14651858.CD005063.pub2.
33. Reoux JP, Malte CA, Kivlahan DR, Saxon AJ. The Alcohol Use Disorders Identification Test (AUDIT) predicts alcohol withdrawal symptoms during inpatient detoxification. Journal of Addictive Diseases. 2002;21(4):81–91. doi: 10.1300/J069v21n04_08.
34. Lee DH, Ha MH, Christiani DC. Body weight, alcohol consumption and liver enzyme activity--a 4-year follow-up study. International Journal of Epidemiology. 2001 Aug;30(4):766–70. doi: 10.1093/ije/30.4.766.
35. Addolorato G, Mirijello A, Leggio L, Ferrulli A, Landolfi R. Management of alcohol dependence in patients with liver disease. CNS Drugs. 2013;27(4):287–99. doi: 10.1007/s40263-013-0043-4.
36. Akshay TV, Shruthilaya CK, Rafiyath VV, Rajesh KS, Subrahmanyam K, Kumar RR. Knowledge, Attitude and Practice of Ischemic Heart Disease Patients towards Their Medication. Journal of Pharmaceutical Research International. 2021;33:256–62. doi: 10.9734/jpri/2021/v33i58A34114
37. Amato L, Minozzi S, Davoli M. Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome. Cochrane Database of Systematic Reviews . 2011 Jun;2011(6):CD008537. doi: 10.1002/14651858.CD008537.pub2
38. Mainerova B, Prasko J, Latalova K, Axmann K, Cerna M, Horacek R, et al. Alcohol withdrawal delirium - diagnosis, course and treatment. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic. 2015;159(1):44–52. doi: 10.5507/bp.2013.089
39. Muzyk AJ, Leung JG, Nelson S, Embury ER, Jones SR. The role of diazepam loading for the treatment of alcohol withdrawal syndrome in hospitalized patients. American Journal on Addictions. 2013;22(2):113–8. doi: 10.1111/j.1521-0391.2013.00307.x.
40. Sachdeva A, Chandra M, Deshpande SN. A comparative study of fixed tapering dose regimen versus symptom-triggered regimen of lorazepam for alcohol detoxification. Alcohol Alcohol. 2014;49(3):287–91. doi: 10.1093/alcalc/agt181.
41. Hassan S, Kumar UU, Mascarenhas V, Suresh G, Raj KCB, Nayak P. A Prospective Study on Adverse Drug Reactions in Inpatients of General Medicine Department in a Tertiary Care Hospital- A clinical Pharmacist-led Study. Journal of Pharmaceutical Research International. 2021;33:111–22. DOI: 10.9734/jpri/2021/v33i35A31880
42. Dervaux A, Laqueille X. Thiamine (vitamin B1) treatment in patients with alcohol dependence. La Presse Médicale. 2017;46(2):165–71. doi: 10.1016/j.lpm.2016.07.025.
43. Nishimoto A, Usery J, Winton JC, Twilla J. High-dose Parenteral Thiamine in Treatment of Wernicke’s Encephalopathy: Case Series and Review of the Literature. In Vivo. 2017;31(1):121–4. doi: 10.21873/invivo.11034.
44. Cook CC, Hallwood PM, Thomson AD. B Vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol Alcohol. 1998;33(4):317–36. doi: 10.1093/oxfordjournals.alcalc.a008400.